Skip to main content
SpringerLink
Log in

Entzündliche, endokrine und toxische Muskelerkrankungen

  • Chapter
Klinische Neurologie

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 209.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zitierte Literatur

  • Argov Z, Tiram E, Eisenberg I et al. (1997) Various types of hereditary inclusion body myopathies map to chromosome 9p1-q1. Ann Neurol 41: 548–551

    Article  CAS  PubMed  Google Scholar 

  • Beyenburg S, Zierz S, Jerusalem F (1994) Einschusstkörpermyositis. Akt Neurol 21: 77–83

    Google Scholar 

  • Bohan A, Peter JB, Bowman RL, Pearson CM (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56: 255–286

    CAS  PubMed  Google Scholar 

  • Bronner IM, Linssen WHJP, van der Meulen MF et al. (2004) Polymyositis: an ongoing discussion about a disease entity. Arch Neurol 61: 132–135

    Article  PubMed  Google Scholar 

  • Brouwer R, Hengstman GJD, Vree Egberts W et al. (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60: 116–123

    Article  CAS  PubMed  Google Scholar 

  • Dalakas MC (1991) Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 325: 1487–1498

    CAS  PubMed  Google Scholar 

  • Dalakas MC (1992 a) Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies. Clin Neuropharmacol 15: 327–351

    CAS  PubMed  Google Scholar 

  • Dalakas MC (1992 b) Inflammatory and toxic myopathies. Curr Opin Neurol 5: 645–654

    CAS  Google Scholar 

  • Dalakas MC (1992 c) Inflammatory myopathies: pathogenesis and treatment. Neuropharmacology 5: 327–351

    Google Scholar 

  • Dalakas MC (1992 d) Inflammatory myopathies. In: Rowland LP, Di-Mauro S (eds) Myopathies. Elsevier, Amsterdam (Handbook of clinical neurology, vol 18, pp 369–390)

    Google Scholar 

  • Dalakas MC, Illa I, Dambrosia JM et al. (1993) A controlled trial of highdose intravenous immune globuline infusions as treatment for dermatomyositis. N Engl J Med 329: 1993–2000

    Article  CAS  PubMed  Google Scholar 

  • Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K (1997) Treatment of inclusion-body myositis with IVIG: a doubleblind, placebo-controlled study. Neurology 48: 712–716

    CAS  PubMed  Google Scholar 

  • De Vere R, Bradley WG (1975) Polymyositis: its presentation, morbidity and mortality. Brain 98: 637–666

    Google Scholar 

  • Eisenberg I, Hochner H, Shemesh M et al. (2001) Physical and transcriptional map of the hereditary inclusion body myopathy locus on chromosome 9p12-p13. Eur J Hum Genet 9: 501–509

    Article  CAS  PubMed  Google Scholar 

  • Hengstman GJD, van Engelen BGM, van Venrooij WJ (2004) Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 16: 69–699

    Google Scholar 

  • Jerusalem F, Zierz S (1991) Muskelerkrankungen. Thieme, Stuttgart New York

    Google Scholar 

  • Kayashima T, Matsuo H, Satoh A et al. (2002) Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J Hum Genet 47: 77–79

    Article  CAS  PubMed  Google Scholar 

  • Kissel JT, Mendell JR, Rammohan KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314: 329–334

    CAS  PubMed  Google Scholar 

  • Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ (1989) Inclusion body myositis. Brain 112: 727–742

    PubMed  Google Scholar 

  • Martinsson T, Darin N, Kyllermann M et al. (1999) Dominant hereditary inclusion body myopathy gene (IBM3) maps to chromosome region 17p13.1. Am J Hum Genet 64: 1420–1426

    Article  CAS  PubMed  Google Scholar 

  • Martinsson T, Oldfords A, Darin N et al. (2000) Autosomal dominant myopathy: missense mutation (Glu-706 → Lys) in the myosin heavy chain Iia gene. Proc Natl Acad Sci USA 97: 14614–14619

    Article  CAS  PubMed  Google Scholar 

  • Moosmann B, Behl C (2004) Selenoprotein synthesis and side-effects of statins. Lancet 363: 892–894

    Article  CAS  PubMed  Google Scholar 

  • Pearson CM, Currie S (1974) Polymyositis and related disorders. In: Walton JN (ed) Disorders of voluntary muscle, 3rd edn. Churchill Livingstone, Edinburgh

    Google Scholar 

  • van der Meulen MF, Bronner IM Hoogendijk JE et al. (2003) Polymyositis: an overdiagnosed entity. Neurology 61: 316–321

    PubMed  Google Scholar 

  • Vasconcelos OM, Raju R, Dalakas MC (2002) GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM. Neurology 59: 1776–1779

    CAS  PubMed  Google Scholar 

Weiterführende Literatur

  • Engel AG, Franzini-Armstrong C (1994) Myology. McGraw-Hill, New York

    Google Scholar 

  • Kissel JT, Mendell JR (1992) The endocrine myopathies. In: Rowland LP, DiMauro S (eds) Myopathies. Elsevier, Amsterdam (Handbook of clinical neurology, vol 18)

    Google Scholar 

  • Mastaglia FL (1992) Toxic myopathies. In: Rowland LP, DiMauro S (eds) Myopathies. Elsevier, Amsterdam (Handbook of clinical neurology, vol 18)

    Google Scholar 

  • Pongratz DE, Reimers CD, Hahn D, Nägele M, Müller-Felber W (1990) Atlas der Muskelkrankheiten. Urban & Schwarzenberg, München

    Google Scholar 

  • Walton J, Karpati G, Hilton-Jones D (1994) Disorders of voluntary muscle. Churchill Livingstone, Edinburgh

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik und Poliklinik für Neurologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, 06097, Halle (Saale)

    K. Traufeller (Dr.) & S. Zierz (Prof. Dr.)

Authors
  1. K. Traufeller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Zierz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Alfried Krupp Krankenhaus, Alfried-Krupp-Str. 21, 45131, Essen

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Traufeller, K., Zierz, S. (2006). Entzündliche, endokrine und toxische Muskelerkrankungen. In: Berlit, P. (eds) Klinische Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31176-9_11

Download citation

  • DOI: https://doi.org/10.1007/3-540-31176-9_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-01982-4

  • Online ISBN: 978-3-540-31176-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation